February 4, 2015

Alliqua BioMedical, Inc to Acquire Celleration

Alliqua BioMedical, Inc (Langhorne, PA) announced that it has signed a definitive agreement to acquire Celleration, Inc.
View Article: WOUNDS

July 25, 2014

Chutes and Ladders

Alliqua BioMedical has announced the appointment of Andrew Africk and Gary Restani to its board of directors.
View Article: Fierce Biotech

May 8, 2014

Wrentham wound care business bought by Alliqua for $4M

A Wrentham company that makes an antimicrobial wound dressing has become the first acquisition of Pennsylvania-based Alliqua, but probably not the last.
View Article: Boston Business Journal

May 6, 2014

Wound-care companies merge in $4M deal

Alliqua Inc. has acquired Choice Therapeutics for about $4 million in cash and stock in a deal involving two wound-care companies.
View Article: Philadelphia Business Journal

April 7, 2014

Alliqua Biomedical’s Advances in Wound Dressings Can Save Lives and Limbs

It is a stunning and frightening statistic: every 30 seconds somewhere in the world a person is losing a limb to diabetes.
View Article: Information About Diabetes

January 28, 2014

Alliqua Roll Continues With Nasdaq Listing

Alliqua’s listing on NASDAQ this week will increase the wound care provider’s visibility in the market, and ultimately increase its shareholder base, says the company’s CEO David Johnson.
View Video: The Street

January 27, 2014

Wound Care Company Graduating to NASDAQ

A Langhorne, Pa., wound-care company has received approval from NASDAQ’s Listing Qualifications Department to list its common stock on the NASDAQ Capital Market.
View Article: Philadelphia Business Journal

January 7, 2014

State of the Art Hydrogels for Wound Care and Drug Delivery: Interview with CEO of Alliqua

Medgadget interviews David Johnson to learn about the latest products offered by the company and to get a better understanding of the next generation of wound care tools.
View Article: MedGadget

December 31, 2013

Top Chiefs Want You To Collaborate, Click In 2014

Alliqua recently partnered with Germany-based Sorbion to exclusively distribute that firm’s wound care products, such as high-tech dressings that prevent infection, throughout the Americas.
View Article: Investor’s Business Daily

December 10, 2013

Alliqua CEO: Celgene Deal Vaults Us to ‘Another Level of Respectability’

FierceDrugDelivery spoke to Alliqua CEO David Johnson about what the company hopes to gain and where it goes from here.
View Article: Fierce Drug Delivery

November 19, 2013

Wound Care Licensing Deal with Celgene Latest Development in Biopharma’s Evolution

Alliqua Biomedical has supplemented its wound care business in a $6 million licensing deal with Celgene’s cellular therapuetics division.
View Article: MedCity News

November 17, 2013

Hydrogels: Building a Better Wound Dressing

Hydrogel dressings are designed to rehydrate the wound bed and reduce wound pain. They can be used on infected wounds and with topical medications.
View Article: Medical Design Technology

November 10, 2013

CEO Spotlight: David Johnson of Alliqua

I love working with very smart and innovative people. I love building something the marketplace needs — it is more fun and energizing to build something rather than tear things down.
View Article: Ostomy Wound Management

November 2013

Hydrogels: A Key Element for Next-Generation Dressings

Alliqua is focusing on hydrogels as a key to superior dressings, and harnessing them in two innovative wound dressings knowns as SilverSeal and Hydress.
View Article: Western Pennsylvania Healthcare News

September 24, 2013

Reinventing the Bandage with Hydrogels

It’s not often that a contract manufacturer enters the medical device market. Alliqua Inc. has made that jump, and has re-imagined itself as a maker of wound-care products.
View Article: Qmed

September 19, 2013

Alliqua CEO: Hydrogel-Based Transdermal Drug Delivery, An Innovative Alternative

Transdermal drug delivery (TDD) represents an attractive alternative to other drug delivery methods and an increasingly promising player in the $142 billion drug delivery market.
View Article: Drug Discovery & Development

September 18, 2013

Biopharm Company Gets New Home, New Focus

Bucks County has a new publicly traded biopharmaceutical company, which is out to grab a chunk of the $6 billion wound-care industry.
View Article: Philadelphia Business Journal

September 09, 2013

Lidocaine Hydrogel Patches Will Be Developed to Treat Localized Acute Pain

US-based wound management and drug delivery company Alliqua is launching a preclinical proof-of-principle study of an experimental hydrogel transdermal patch containing lidocaine.
View Article: Manufacturing Chemist

August 02, 2013

NewCo on the Go: Alliqua CEO Touts Milestones of the ‘Vibrant Little Company’

Alliqua, a wound management and drug delivery company, has seen a lot of changes in the past six months, starting at the top.
View Article: Medical Device Daily